Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on Cleo Diagnostics’ (ASX:COV) partnership with The Royal Women’s Hospital in Melbourne to participate in its ovarian cancer trial.

The company aims to bring to market a simple blood test for the accurate and early diagnosis of the cancer based on a novel patented biomarker.

Tune in to get the latest.

Read MoreAusbiotechHealthMedtech

Featured Companies

You might be interested in